|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 1/34 | (2006.01) |
| C12N2740/13063 | (2013.01) | ||
| C07K 14/745 | (2006.01) | ||
| C12Y 304/21021 | (2013.01) | ||
| C12N 9/64 | (2006.01) | ||
| C07K 14/745 | (2013.01) | ||
| C12N 7/06 | (2006.01) | ||
| C12N 7/00 | (2013.01) | ||
| C12N 9/6437 | (2013.01) | ||
| A61P 7/02 | (2018.01) | ||
| A61P 7/04 | (2018.01) |
| (11) | Number of the document | 3594222 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19186952.8 |
| Date of filing the European patent application | 2004-12-01 | |
| (97) | Date of publication of the European application | 2020-01-15 |
| (45) | Date of publication and mention of the grant of the patent | 2022-08-03 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 200301775 | 2003-12-01 | DK |
| (72) |
HANSEN, Thomas Budde , DK
HALKJÆR, Erik , DK
PREUSS, Turid , DK
TOMODA, Lene Vædele Madsen , DK
JOHANSEN, Nina , DK
CHRISTENSEN, Jesper , DK
|
| (73) |
Novo Nordisk Health Care AG ,
The Circle 32/38
8058 Zürich-Flughafen,
CH
|
| (54) | VIRUS FILTRATION OF LIQUID FACTOR VII COMPOSITIONS |
| VIRUS FILTRATION OF LIQUID FACTOR VII COMPOSITIONS |